Cancer cells undergo EMT in the presence of transforming growth factor beta 1 (TGF-β1), inducing a phenotypic transformation from a differentiated adherent epithelial phenotype to a more motile mesenchymal phenotype that contributes to metastatic invasion [14,15]. This evidence concerns the gene TGFB1 and cancer.